AYTU BIOPHARMA, INC Other Non-Current Assets
AYTU BIOPHARMA, INC (AYTU) had Other Non-Current Assets of $601.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-09-22
- 2026-06-30: Other Assets, Noncurrent $601.00K.
- 2026-03-31: Other Assets, Noncurrent $556.00K.
- 2025-12-31: Other Assets, Noncurrent $738.00K.
- 2025-09-30: Other Assets, Noncurrent $939.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $601.00K 10-K · filed 2026-09-22 | |
| 2026-03-31 | $556.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $738.00K 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $939.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.20M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $1.32M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.52M 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $1.97M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.19M 10-K · filed 2025-09-23 | $2.23M 10-K · filed 2024-09-26 |
| 2024-03-31 | $889.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $907.00K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $772.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.54M 10-K · filed 2024-09-26 | $792.00K 10-K · filed 2023-10-12 |
| 2023-03-31 | $892.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $821.00K 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $829.00K 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | $766.00K 10-K · filed 2023-10-12 | |
| 2022-03-31 | $774.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $457.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $465.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $465.00K 10-K · filed 2022-09-27 | |
| 2021-03-31 | $164.95K 10-Q · filed 2021-05-17 | |
| 2020-09-30 | $16.02M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $33.00K 10-K · filed 2021-09-28 | $16.59M 10-K · filed 2020-10-06 |
| 2020-03-31 | $17.16M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $17.72M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $18.29M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $18.86M 10-K · filed 2020-10-06 | |
| 2019-03-31 | $19.43M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $20.00M 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $10.67M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $11.12M 10-K · filed 2019-09-26 | |
| 2018-03-31 | $8.24M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $8.57M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $8.90M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $9.23M 10-K · filed 2018-09-06 | |
| 2017-03-31 | $9.56M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $9.89M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $10.22M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $10.55M 10-K · filed 2017-08-31 | |
| 2015-06-30 | $0.00 10-K · filed 2016-09-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |